Molecular diagnostics in pathology

被引:9
作者
Stenzinger, A. [1 ]
Penzel, R. [1 ]
Endris, V. [1 ]
Weichert, W. [1 ,2 ]
机构
[1] Univ Klinikum Heidelberg, Inst Pathol, D-69120 Heidelberg, Germany
[2] Natl Ctr Tumorerkrankungen, Heidelberg, Germany
关键词
pathology; molecular diagnostics; tissue; pathogenic organisms; immunohistochemistry; sequencing; mutations; oncology; CANCER; BIOMARKERS; GENOMICS;
D O I
10.1055/s-0033-1343106
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tissue-based molecular diagnostics is a fast growing diagnostic field, which already complements morphologic classifications in many cases. Pathology based molecular diagnosis is performed almost exclusively on paraffin embedded material and always in conjunction with histopathology. Besides the classic field of tissue based detection of pathogenic organisms such as bacteria, viruses and fungi, molecular diagnostics of tumor tissue is one of the current hot topics in oncology. In this context the detection of predictive molecular biomarkers, such as specific mutations, allows patient stratification for individually tailored treatment strategies and thereby is one of the key components of individualized patient care in oncology. The rapidly growing number of clinically relevant predictive biomarkers together with impressive technical advances, specifically the development of massive parallel sequencing, will modify the care of patients with malignant diseases. Pathology, therefore, has returned in the very center of interdisciplinary patient care. © Georg Thieme Verlag KG · Stuttgart · New York.
引用
收藏
页码:1061 / 1068
页数:8
相关论文
共 15 条
[1]   Molecular Pathology of Non-Small Cell Lung Cancer A Practical Guide [J].
Aisner, Dara L. ;
Marshall, Carrie B. .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 (03) :332-346
[2]  
[Anonymous], FDN DIAGNOSTIC PATHO
[3]   Cancer genomics: from discovery science to personalized medicine [J].
Chin, Lynda ;
Andersen, Jannik N. ;
Futreal, P. Andrew .
NATURE MEDICINE, 2011, 17 (03) :297-303
[4]  
Coleman WB, 2009, MOLECULAR PATHOLOGY: THE MOLECULAR BASIS OF HUMAN DISEASE, P1
[5]   HER2 Testing and Targeted Therapy in Advanced Gastric Cancer [J].
Hoehler, Thomas ;
Rueschoff, Josef ;
Ridwelski, Karsten ;
Moehler, Markus .
ONKOLOGIE, 2010, 33 :26-30
[6]   Predictive biomarkers: a paradigm shift towards personalized cancer medicine [J].
La Thangue, Nicholas B. ;
Kerr, David J. .
NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (10) :587-596
[7]   The molecular biology of head and neck cancer [J].
Leemans, C. Rene ;
Braakhuis, Boudewijn J. M. ;
Brakenhoff, Ruud H. .
NATURE REVIEWS CANCER, 2011, 11 (01) :9-22
[8]   From morphologic to molecular: established and emerging molecular diagnostics for breast carcinoma [J].
Portier, Bryce P. ;
Gruver, Aaron M. ;
Huba, Michael A. ;
Minca, Eugen C. ;
Cheah, Alison L. ;
Wang, Zhen ;
Tubbs, Raymond R. .
NEW BIOTECHNOLOGY, 2012, 29 (06) :665-681
[9]   Quantitative Analysis of Diagnostic Guidelines for HER2-Status Assessment [J].
Stenzinger, Albrecht ;
von Winterfeld, Moritz ;
Aulmann, Sebastian ;
Warth, Arne ;
Weichert, Wilko ;
Denkert, Carsten ;
Rueschoff, Josef ;
Dietel, Manfred ;
Klauschen, Frederick .
JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (03) :199-205
[10]   Visceral leishmaniasis in a patient with AIDS: early pathological diagnosis using conventional histology, PCR and electron microscopy is the key for adequate treatment [J].
Stenzinger, Albrecht ;
Nemeth, Johannes ;
Klauschen, Frederick ;
Schewe, Christiane ;
Ladhoff, Axel-Michael ;
Muckenhuber, Alexander ;
Schuermann, Mariana ;
Schuermann, Dirk ;
Weichert, Wilko .
VIRCHOWS ARCHIV, 2012, 460 (03) :357-360